A&Z Pharmaceutical, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 180 Oser Avenue Suite 300, Hauppauge, New York (NY) 11788, United States (USA)
- Operations here
- manufacture
- FDA identifiers
- FEI 1000521505 · DUNS 080225262
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-09-26
- VAIDrug Quality Assurance2017-11-22
- VAIDrug Quality Assurance2015-03-31
- VAIDrug Quality Assurance2014-06-03
Drugs this plant is listed as making
8 distinct drugs across 27 products name this site in their FDA label.
- Benztropine MesylateScieGen Pharmaceuticals Inc
- Buspirone hydrochlorideRadha Pharmaceuticals, Inc.
- Folic AcidQuagen Pharmaceuticals Llc
- HaloperidolAiPing Pharmaceutical, Inc
- MeloxicamAiPing Pharmaceutical, Inc
- MethimazoleAiPing Pharmaceutical, Inc.
- MetoclopramideScieGen Pharmaceuticals, Inc.
- Sotalol HydrochlorideAiPing Pharmaceutical, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.